Linghao Wang
Impact in
-
- Chronic Kidney Disease and Diabetes
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- Inflammasome and immune disorders 4
- Connective Tissue Growth Factor Research 2
- Circular RNAs in diseases 2
- Ginseng Biological Effects and Applications 2
- TGF-β signaling in diseases 2
-
- Autophagy in Disease and Therapy 2
- Co-authors
- Ke Chen (6 shared papers)Zhaohui Mo (5 shared papers)Fang Wang (2 shared papers)Xin-xing Wan (1 shared paper)Zi Guo (1 shared paper)Honghui He (2 shared papers)Fang Wang (1 shared paper)Gaoyun Hu (4 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)American Journal of Nephrology (1 paper)Cell Death Discovery (1 paper)International journal of agricultural and biological engineering (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Linghao Wang
23 papers receiving 379 citations
Peers
Comparison fields: 5 of 82
- Nephrology 38
- Cancer Research 71
- Molecular Biology 217
- Immunology 51
- Pharmacology 21
Countries citing papers authored by Linghao Wang
This map shows the geographic impact of Linghao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linghao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linghao Wang more than expected).
Fields of papers citing papers by Linghao Wang
This network shows the impact of papers produced by Linghao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linghao Wang. The network helps show where Linghao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Linghao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 81 | |
| 2 | 2015 | 62 | |
| 3 | 2016 | 35 | |
| 4 | 2017 | 34 | |
| 5 | 2011 | 30 | |
| 6 | 2010 | 27 | |
| 7 | 2015 | 22 | |
| 8 | Fluorofenidone suppresses epithelial-mesenchymal transition and the expression of connective tissue growth factor via inhibiting TGF-beta/Smads signaling in human proximal tubular epithelial cells. | 2011 | 21 |
| 9 | 2017 | 16 | |
| 10 | 2024 | 10 | |
| 11 | 2019 | 10 | |
| 12 | 2024 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2014 | 6 | |
| 15 | 2022 | 5 | |
| 16 | 2018 | 4 | |
| 17 | 2016 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2023 | 2 |
About Linghao Wang
Linghao Wang is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Surgery and Computer Networks and Communications, having authored 25 papers that have together received 389 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (4 papers), MicroRNA in disease regulation (3 papers), Connective Tissue Growth Factor Research (2 papers), Circular RNAs in diseases (2 papers), Ginseng Biological Effects and Applications (2 papers), Autophagy in Disease and Therapy (2 papers), TGF-β signaling in diseases (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Nephrology (38 citations), Cancer Research (71 citations), Molecular Biology (217 citations), Immunology (51 citations) and Pharmacology (21 citations). Linghao Wang has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Ke Chen, Zhaohui Mo, Fang Wang, Xin-xing Wan, Zi Guo, Honghui He, Fang Wang, Gaoyun Hu, Qiongjing Yuan and Lijian Tao. Their work appears in journals such as Biochemical and Biophysical Research Communications, American Journal of Nephrology, Cell Death Discovery, International journal of agricultural and biological engineering and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.